Comparing Mycophenolic Acid vs Myfortic
| Mycophenolic acid | Myfortic (mycophenolic acid) |
|
|---|
| Mycophenolic acid | Myfortic (mycophenolic acid) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Dermatomyositis, Rejection Prophylaxis. Mycophenolic acid may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Dermatomyositis, Rejection Prophylaxis. Myfortic may also be used for purposes not listed in this medication guide. |
Related suggestions Dermatomyositis
Rejection Prophylaxis
|
|||||||||||||||
| More about Mycophenolic acid | More about Myfortic (mycophenolic acid) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Mycophenolic acid has an average rating of 8.8 out of 10 from a total of 8 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
Myfortic has an average rating of 8.8 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Mycophenolic acid side effects |
View all Myfortic side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Mycophenolic acid prices |
View all Myfortic prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Myfortic |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
16 hours |
16 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 339 drugs are known to interact with Mycophenolic acid:
|
A total of 339 drugs are known to interact with Myfortic:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
February 27, 2004 |
February 27, 2004 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Myfortic
Myfortic (mycophenolic acid) is used to prevent your body from rejecting a kidney transplant ...
Nulojix
Nulojix (belatacept) is used in combination with other medications to prevent organ rejection after ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Afinitor
Afinitor prevents the growth of cancer cells and is used to treat advanced kidney cancer. Learn ...
Afinitor Disperz
Afinitor Disperz is used for subependymal giant cell astrocytoma, tuberous sclerosis complex
Arava
Arava (leflunomide) is used to treat the symptoms of rheumatoid arthritis and help reduce joint ...
Arzerra
Arzerra is used to treat chronic lymphocytic leukemia (CLL), usually in combination with other ...
Aubagio
Aubagio (teriflunomide) is used to reduce flare-ups in people with relapsing multiple sclerosis ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.